RENO, Nev., Sept. 19, 2011 /PRNewswire/ -- Visual Healthcare Corp. (the "Company") (PINKSHEETS: VSHC) announces that it has published its year-end disclosure statement and financial results. These are available on the OTC Markets site as well as on the company website at www.visualhealthcarecorp.com.
The Company is pleased to report that its 4th Quarter results and year-end have been a major turnaround as the Company moves toward establishing a stable position within the global Healthcare IT marketplace.
Revenues were significantly up for fiscal year 2011 at $2,093,104, with net income of $30,291, both spurred largely by the impact of current U.S. Administration's healthcare policies on the marketplace.
"We have had a large increase in demand for our products in the past year as healthcare reform has taken hold in earnest," says CEO Gerard Dab. "We expect to continue to grow revenues by adding new technologies to our portfolio, and continue to license our platforms and software to an increasingly large stable of licensees and will likely maintain our growth rate for the next few years."
There will be a conference call for analysts to discuss company results and prospects next Wednesday, September 21st, 2001 at 1PM EDT (New York time) to be hosted by company Chairman Gerard Dab. The following are the dial in and access numbers: Dial-in number is (209) 647-1000. Access code is 910071.
Members of the public are welcome.
The full disclosure document and detailed financial statements and results can be found at http://www.otcmarkets.com/financialReportViewer?symbol=VSHC&id=60642
ABOUT VISUAL HEALTHCARE
Visual Healthcare Corp., since 1998, designs, creates and develops innovative information platforms, specifically conceived for the automation of a wide range of scientific disciplines. These include pharmaceutical research, clinical trials, laboratory automation, true quality assurance tools, total quality control applications. They also include quantitative analytic tools such as proprietary frameworks for electronic health records, electronic prescription, infection and disease control, and smart cancer registries. The company's extensive portfolio of proprietary technologies is the result of a unique collaboration between senior clinicians from the McGill University Faculty of Medicine and affiliated tertiary care centers, medical software architects, and a Fortune 100 healthcare service company, investing some $50 million in the process. The Company licenses its technology to operating companies in exchange for an equity stake or a royalty stream. It owns significant stakes in various companies including VisualMED Clinical Solutions Corp. (PINKSHEETS: VMCS), a leader in the field of smart electronic health records.
For more information, please visit: www.visualhealthcarecorp.com.
FORWARD- LOOKING STATEMENTS
Except for historical information provided herein, this press release may contain information and statements of a forward-looking nature concerning the future performance of the Company. These statements are based on suppositions and uncertainties as well as on management's best possible evaluation of future events. Such factors may include, without excluding other considerations, fluctuations in quarterly results, evolution in customer demand for the Company's products and services, the impact of price pressures exerted by competitors, and general market trends or economic changes. As a result, readers are advised that actual results may differ from expected results.
Gerard Dab, CEO
Visual Healthcare Corp.
SOURCE Visual Healthcare Corp.